Ken Griffin Nautilus Biotechnology, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 14,000 shares of NAUT stock, worth $31,919. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,000
Previous 12,100
15.7%
Holding current value
$31,919
Previous $36,000
13.89%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NAUT
# of Institutions
77Shares Held
63.1MCall Options Held
14KPut Options Held
1.8K-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$37.2 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$28.7 Million0.78% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$16.4 Million0.6% of portfolio
-
Madrona Venture Group, LLC6.02MShares$13.7 Million15.07% of portfolio
-
Black Rock Inc. New York, NY3.73MShares$8.51 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $284M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...